[{"from": "human", "value": "Provide a description of this molecule. [C][C][C][Branch1][Ring1][C][C][C][O][C][=Branch1][C][=O][C@H1][Branch1][C][C][N][P@][=Branch1][C][=O][Branch2][Ring2][=Branch1][O][C][C@@H1][C@H1][Branch2][Ring1][=C][C@H1][Branch2][Ring1][=Branch2][C@][Branch1][Ring2][O][Ring1][Branch1][Branch1][Ring1][C][#N][C][=C][C][=C][N][Ring1][Branch1][N][=C][N][=C][Ring1][=Branch1][N][O][O][O][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is an antiviral nucleotide analogue used for therapy of severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection. Remdesivir therapy is given intravenously for 3 to 10 days and is frequently accompanied by transient, reversible mild-to-moderate elevations in serum aminotransferase levels but has been only rarely linked to instances of clinically apparent liver injury, its hepatic effects being overshadowed by the systemic effects of COVID-19."}]